1. Acute Pain Therapeutics - Pipeline Assessment and Market Forecasts to
2019
GlobalData, the industry analysis specialist, has released its new report, “Acute Pain
Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an
essential source of information and analysis on the global Acute Pain Therapeutics market.
The report identifies the key trends shaping and driving the global Acute Pain Therapeutics
market. The report also provides insights on the prevalent competitive landscape and the
emerging players expected to significantly alter the market positioning of the current
market leaders. Most importantly, the report provides valuable insights on the pipeline
products within the global Acute Pain Therapeutics sector. This report is built using data
and information sourced from proprietary databases, primary and secondary research and
in-house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the key drivers and challenges of the Acute Pain Therapeutics
market. Its scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Acute Pain
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic
classes.
- Analysis of the current and future competition in the seven key countries Acute Pain Therapeutics
market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently
researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and
the implications for the Acute Pain Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Acute Pain Therapeutics market
Get more information of this report @ http://www.reportsnreports.com/reports/167921-acute-pain-
therapeutics-pipeline-assessment-and-market-forecasts-to-2019.html
Reasons to buy
The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products
and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Acute Pain
Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies, market
segments and companies likely to impact the global Acute Pain Therapeutics market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by
analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-
strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that

2. present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Acute Pain Therapeutics market landscape? – Identify,
understand and capitalize.
Report Details:
Published: June 2012
No. of Pages: 98
Price: Single User License: US $ 3995 Corporate User License: US $ 11985
Major points covered in Table of Contents of this report include:
List of Tables 5
1.2 List of Figures 6
2 Acute Pain Therapeutics - Introduction 7
2.1 Disease Overview 7
2.2 Epidemiology 8
2.3 Etiology 11
2.4 Pathophysiology 11
2.5 Symptoms 13
2.6 Diagnosis 14
2.6.1 Unidimensional Pain Intensity Scales 14
2.6.2 Multidimensional Pain Scales 16
2.6.3 Commonly Used Diagnosis Tests 16
2.7 Treatment and Management Options 16
2.7.1 Pharmacologic Therapy 16
2.7.2 Intervention/Surgical Procedures 17
2.7.3 Non-Pharmacologic Approaches 17
2.8 Referral Pathway 19
2.9 GlobalData Pipeline Report Guidance 20
3 Acute Pain Therapeutics - Market Characterization 21
3.1 Acute Pain Therapeutics Market Size (2006-2011) - Global 21
3.2 Acute Pain Therapeutics Market Forecast (2011-2019) - Global 23
3.3 Acute Pain Therapeutics Market Size (2006-2011) - The US 24
3.4 Acute Pain Therapeutics Market Forecast (2011- 2019) - The US 25
3.5 Acute Pain Therapeutics Market Size (2006-2011) - France 26
3.6 Acute Pain Therapeutics Market Forecast (2011-2019) - France 27
3.7 Acute Pain Therapeutics Market Size (2006-2011) - Germany 28
3.8 Acute Pain Therapeutics Market Forecast (2011-2019) - Germany 29

3. 3.9 Acute Pain Therapeutics Market Size (2006-2011) - Italy 30
3.10 Acute Pain Therapeutics Market Forecast (2011-2019) - Italy 31
3.11 Acute Pain Therapeutics Market Size (2006-2011) - Spain 32
3.12 Acute Pain Therapeutics Market Forecast (2011-2019) - Spain 33
3.13 Acute Pain Therapeutics Market Size (2006-2011) - The UK 34
3.14 Acute Pain Therapeutics Market Forecast (2011-2019) - The UK 35
3.15 Acute Pain Therapeutics Market Size (2006-2011) - Japan 36
3.16 Acute Pain Therapeutics Market Forecast (2011-2019) - Japan 37
3.17 Drivers and Barriers for the Acute Pain Therapeutics Market 38
3.17.1 Drivers for the Acute Pain Therapeutics Market 38
3.17.2 Barriers for the Acute Pain Therapeutics Market 38
3.18 Opportunity and Unmet Need 38
3.19 Key Takeaway 40
4 Acute Pain Therapeutics - Competitive Assessment 41
4.1 Overview 41
4.2 Strategic Competitor Assessment 41
4.3 Product Profiles for the Major Marketed Products in the Acute Pain Therapeutics Market 42
4.3.1 Celebrex (celecoxib) 42
4.3.2 DepoDur (morphine sulfate extended-release liposome injection) 43
4.3.3 Ofirmev (acetaminophen injection) 45
4.3.4 Oxecta (oxycodone hydrochloride Tablet) 46
4.3.5 Nucynta (tapentadol) 47
4.3.6 Dilaudid (hydromorphone hydrochloride) 49
4.3.7 Sprix (ketorolac tromethamine) Nasal Spray 50
4.3.8 Zipsor (diclofenac potassium) 51
4.3.9 Flector Patch (diclofenac epolamine) 52
4.3.10 Vicoprofen (hydrocodone bitartrate 7.5mg and ibuprofen 200mg) 54
4.4 Key Takeaway 56
5 Acute Pain Therapeutics - Pipeline Assessment 57
5.1 Overview 57
5.2 Strategic Pipeline Assessment 57
5.3 Acute Pain Therapeutics Pipeline - Pipeline by Phases of Development 58
5.3.1 Acute Pain Therapeutics - Filed Pipeline 58
5.3.2 Acute Pain Therapeutics - Phase III Pipeline 59
5.3.3 Acute Pain Therapeutics - Phase II Pipeline 59
5.3.4 Acute Pain Therapeutics - Phase I Pipeline 60
5.3.5 Acute Pain Therapeutics - IND Filed Pipeline 60
5.3.6 Acute Pain Therapeutics - Pre-clinical Pipeline 60
5.3.7 Technology Trends Analytic Framework 61
5.4 Acute Pain Therapeutics Market - Pipeline by Mechanism of Action 63
5.5 Acute Pain Therapeutics - Promising Drugs under Clinical Development 64
5.6 Molecule Profiles for Promising Drugs under Clinical Development 64

4. 5.6.1 MoxDuo IR (morphine and oxycodone) 64
5.6.2 Dyloject (diclofenac sodium Fast-push Intravenous Bolus Injection) 65
5.6.3 Ketotransdel (ketoprofen 10% Cream) 66
5.6.4 MRX-7EAT (etodolac + lidocaine Topical Patch) 67
5.7 Key Takeaway 67
6 Acute Pain Therapeutics - Clinical Trials Mapping 68
6.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 68
6.2 Clinical Trials by Phase 69
6.3 Clinical Trials by Trial Status 70
6.4 Prominent Sponsors 71
6.5 Top Companies Participating in Acute Pain Therapeutics Clinical Trials 73
7 Acute Pain Therapeutics - Strategic Assessment 74
7.1 Key Events Impacting the Future Market 74
7.2 Acute Pain Therapeutics: Implications for Future Market Competition 74
8 Acute Pain Therapeutics - Future Players 76
8.1 Introduction 76
8.2 Company Profiles 77
8.2.1 Grunenthal 77
8.2.2 QRxPharma 77
8.2.3 Iroko Pharma 78
8.2.4 Hospira 78
8.2.5 Transdel Pharma 78
8.2.6 MEDRx Co. 79
9 Acute Pain Therapeutics - Appendix 80
9.1 Definitions 80
9.2 Acronyms 80
9.3 Bibliography 81
9.4 Research Methodology 82
9.4.1 Coverage 83
9.4.2 Secondary Research 83
9.4.3 Forecasting 83
9.4.4 Primary Research 86
9.4.5 Expert Panel Validation 87
9.5 Contact Us 87
9.6 Disclaimer 87
Related Reports @ http://www.reportsnreports.com/publisher/globaldata/
Contact:
TX, Dallas North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas 75252.

5. Tel: + 1 888 391 5441
sales@reportsandreports.com
Connect With Us: